跳至主要内容
临床试验/NL-OMON49224
NL-OMON49224已完成不适用

The Personalized Parkinson Project - de novo cohort - PPP NOVO

Radboud Universitair Medisch Centrum0 个研究点目标入组 144 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
144

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Prior to enrollment in this clinical investigation, candidates must meet ALL of
  • the following criteria:
  • * Subject has never been treated before with any symptomatic dopaminergic drug
  • treatment for Parkinson*s disease and is not expected to start treatment for
  • motor symptoms of PD within 52 weeks from baseline.
  • * Subject has Parkinson*s disease of <=2 years of duration, defined as the time
  • since the diagnosis was made by a neurologist.
  • * Subject is an adult, at least 18 years of age.
  • * Subject can read and understand Dutch.
  • * Subject has completed the CMO-approved Informed Consent.
  • * Subject is willing, competent, and able to comply with all aspects of the
  • protocol, including follow-up schedule and biospecimen collection.

排除标准

  • Candidates must be excluded from this study if ANY of the following criteria
  • * Subject is pregnant or breastfeeding.
  • * Subject has co-morbidities that would hamper interpretation of
  • parkinsonian disability, such as coincident musculoskeletal abnormalities, in
  • the opinion of the lnvestigator.
  • * Subject is allergic to nickel.

研究者

相似试验

The Personalized Parkinson Project - de novo cohort | 临床试验